About Amblyotech
Amblyotech is a company based in Atlanta (United States) founded in 2013 was acquired by Novartis in April 2020. Amblyotech has raised $1.84 million across 3 funding rounds from investors including Novartis and Jumpstart Foundry. Amblyotech operates in a competitive market with competitors including NovaVision, Sight Science, Bionic Vision Technologies, Ooyby and Envision Solutions, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Amblyotech
Amblyotech has successfully raised a total of $1.84M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $735.33 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Amblyotech
Amblyotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis and Jumpstart Foundry.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Locked | Locked | Locked |
Investor details for Amblyotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amblyotech
Investment portfolio details for Amblyotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amblyotech
Detailed financials for Amblyotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amblyotech Comparisons
Peer comparison for Amblyotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amblyotech
Amblyotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NovaVision, Sight Science, Bionic Vision Technologies, Ooyby and Envision Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive devices are developed for vision restoration in stroke survivors.
|
|
| Locked | Locked | Locked |
Visual rehabilitation for brain-injured patients with field loss is provided.
|
|
| Locked | Locked | Locked |
Visual prostheses are developed to restore sight for the blind.
|
|
| Locked | Locked | Locked |
Smart devices are provided for vision rehabilitation and training.
|
|
| Locked | Locked | Locked |
Delivers comprehensive computer-based therapies for vision restoration.
|
Detailed competitors of Amblyotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amblyotech
Complete news archive for Amblyotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amblyotech
Amblyotech was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Amblyotech is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Amblyotech is a funded company, having raised a total of $1.84M across 3 funding rounds to date.
Amblyotech was founded in 2013 in Atlanta, United States, within the health technology sector. An application is offered for treating Amblyopia, an eye disorder affecting vision coordination, using tablet or smartphone devices paired with 3D glasses. Visual stimuli are delivered separately to each eye during attention-based games, encouraging brain adaptation for improved acuity in the affected eye. Conventional methods like patching, atropine drops, or surgery are not required.
Amblyotech's top competitors include Sight Science, NovaVision and Bionic Vision Technologies.
Amblyotech has 2 investors. Key investors include Novartis, and Jumpstart Foundry.